The UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Read MoreIn a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
Read MoreUC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
Read MoreUC President Michael Drake was at the UC Davis Health campus to help induct the new presidential chair in vitreoretinal science. The inaugural appointment of world-renowned physician Paul A. Sieving was held Sept. 17 with recognition of Neil and MJ Kelly and their generous donation that established the Kelly Presidential Chair in Vitreoretinal Science.
Read MoreProfessors David Segal and Deborah Lieu have received Discovery Stage Research Projects awards from the California Institute for Regenerative Medicine (CIRM). The grants will fund cell gene therapy for Angelman syndrome and building the first biopacemaker
Read MoreA groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.
Read MoreA UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.
Read MoreCalifornia’s stem cell agency awarded funding to UC Davis Health researchers for the first human clinical trial using stem cells to treat spina bifida.
Read MoreA UC Davis Health fetal surgeon and a stem cell scientist have received approval from the U.S. Food and Drug Administration to test a one-of-a-kind spina bifida treatment that combines surgery with stem cells.
Read MoreUC Davis Health spine surgeons are using unique imaging technology that provides head-to-toe, 3D images of bones and is safer than other options.
Read MoreAijun Wang, a UC Davis associate professor of surgery and biomedical engineering, has been awarded a $500,000 grant to create the next generation of vascular grafts for dialysis patients with end-stage kidney disease.
Read MoreBlocking an enzyme — soluble epoxide hydrolase, or sEH — linked with inflammation makes it possible for stem cells to repair damaged heart tissue.
Read MoreSchool of Medicine Dean Allison Brashear is the newest board member of the state’s stem cell agency, the California Institute for Regenerative Medicine.
Read MoreDean Brashear during the UC Davis School of Medicine Office of Research Expo showcased some of the exciting research happening at the School of Medicine and called for more clinical trials to be open for patients.
Read MoreOn Oct. 15, UC Davis Health dermatologist and autoimmune disease specialist Emanual Maverakis will be inducted as an Academy Fellow of the California Academy of Sciences, a rare distinction for a physician.
Read MoreUC Davis Health researchers announced promising findings from interim results of HOPE-2 clinical trial for Duchenne muscular dystrophy.
Read MoreJan Nolta, director of UC Davis' stem cell program, answers questions about treatments and therapies using stem cells, including what people should be very cautious about when a clinic attaches a pricetag to its services.
Read MoreA pair of English bulldog puppies are the first patients to be successfully treated with a unique therapy — a combination of surgery and stem cells — developed at the University of California, Davis, to help preserve lower-limb function in children with spina bifida.
Read More